Search
iShares Genomics Immunology and Healthcare ETF
IDNAAdd to Watchlist
42.310USD
+0.890+2.15%
Close 11-06 16:00（ET）
13.02KVolume
548.71KTurnover
Today
+2.15%
5 Days
-1.05%
1 Month
+3.50%
6 Months
+43.79%
Year to Date
+62.23%
1 Year
+72.55%
Key Figures
41.430Open
41.420Prev. Close
42.570High
40.980Low
13.02KVolume
548.71KTurnover
0.06Volume Ratio
44.15052wk High
24.76352wk Low
142.48KAvg Volume
0.69%Div Yield
0.281Est. Annual Div.
ThemeInvestment Segment
NoInverse ETF
NoLeveraged ETF
--Leverage Factor
40.927NAV
USDNAV Currency
3.93P/B
17.93Price to earnings ratio
iShares Genomics Immunology and Healthcare ETF Profile
Ticker SymbolIDNA
Asset ClassEquity
Fund ManageriShares
DomicileUS
Expense Ratio0.47%
Founded at2019-06-11
Tracking IndexNYSE FactSet Global Genomics and Immuno Biopharma Index
IDNA was created on 2019-06-11 by iShares. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 315.08m in AUM and 50 holdings. IDNA tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering.
Top 10 Holdings
No.Name
Price
Change
Chg %
Shares Held
Weight
Market Value
Watchlist
MODERNA
MRNA
254.190
+12.730
+5.27%
194.11K
12.14%
$38.84M
TWIST BIOSCIENCE
TWST
120.790
+0.180
+0.15%
133.03K
5.82%
$18.61M
IOVANCE BIOTHERAPEUTICS INC
IOVA
8.040
+0.300
+3.88%
1.12M
4.94%
$15.80M
4
GENMAB
GMAB.CO
--
0.000
--
37.37K
4.63%
$14.81M
5
TAKEDA PHARMACEUTICAL
4502.T
--
0.000
--
299.20K
3.81%
$12.19M
6
REGENERON PHARMACEUTICALS
REGN
904.350
+1.450
+0.16%
14.49K
3.65%
$11.67M
7
REVOLUTION MEDICINES
RVMD
192.280
+14.630
+8.24%
61.71K
3.61%
$11.54M
8
CARIS LIFE SCIENCES
CAI
25.230
-0.800
-3.07%
354.08K
3.54%
$11.33M
9
EXELIXIS INC
EXEL
69.570
+0.860
+1.25%
174.64K
3.52%
$11.27M
10
MERCK & CO INC
MRK
146.730
-0.210
-0.14%
76.27K
3.46%
$11.08M
iShares Genomics Immunology and Healthcare ETF Technical Analysis
Technical Indicators
Sell
Summary
Neutral
Moving Average
Buy
iShares Genomics Immunology and Healthcare ETF News
More news coming soon, stay tuned...
Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of iShares Genomics Immunology and Healthcare ETF (IDNA)?
The current price of iShares Genomics Immunology and Healthcare ETF (IDNA) is 42.31. Market data may be delayed; please refer to the timestamp displayed on the page.
What is the 52-week high of iShares Genomics Immunology and Healthcare ETF?
The 52-week high of iShares Genomics Immunology and Healthcare ETF is 44.15. Please refer to the page timestamp for the latest data.
What is the 52-week low of iShares Genomics Immunology and Healthcare ETF?
The 52-week low of iShares Genomics Immunology and Healthcare ETF is 24.76. Please refer to the page timestamp for the latest data.
What is the NAV of iShares Genomics Immunology and Healthcare ETF?
The NAV of iShares Genomics Immunology and Healthcare ETF is 40.93 today. NAV represents the fund’s total assets minus its liabilities and helps indicate its underlying per-share value.
How is iShares Genomics Immunology and Healthcare ETF (IDNA) performing?
The trading turnover of iShares Genomics Immunology and Healthcare ETF (IDNA) is 548.71K. Its price changed by 1.80% over the past month, while its one-year return is 69.74%. View the iShares Genomics Immunology and Healthcare ETF price chart for more details.
Is iShares Genomics Immunology and Healthcare ETF (IDNA) a safe investment?
No investment is completely risk-free. The risk level of iShares Genomics Immunology and Healthcare ETF (IDNA) depends on its underlying assets, strategy, liquidity, fees, and market conditions. Diversification may reduce potential losses but cannot eliminate them, and past performance does not guarantee future results. Before investing, consider whether the fund aligns with your goals and risk tolerance. This is not investment advice.